{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:51:19Z","timestamp":1771512679962,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ck0106742h0003"],"award-info":[{"award-number":["24ck0106742h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.leukres.2025.107714","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:49:37Z","timestamp":1748432977000},"page":"107714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Treatment strategy for indolent adult T-cell leukemia-lymphoma"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-890X","authenticated-orcid":false,"given":"Takeharu","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2025.107714_bib1","series-title":"Adult T-Cell Leukemia","author":"Takatsuki","year":"1994"},{"key":"10.1016\/j.leukres.2025.107714_bib2","unstructured":"K. Karube, J. Chan, S.S. Dave, B.L. Wood, , 2024, Adult T-cell leukemia\/lymphoma. Hematolymphoid Tumors, WHO Classification of Tumors, fifth ed., Volume 11, WHO Classification of Tumors Editorial Board, 2024.."},{"issue":"2","key":"10.1016\/j.leukres.2025.107714_bib3","first-page":"165","article-title":"Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma","volume":"13","author":"Shimoyama","year":"1983","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107714_bib4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V62.4.758.758","article-title":"A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases","volume":"62","author":"Yamaguchi","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/blood.V66.1.120.120","article-title":"Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus","volume":"66","author":"Kinoshita","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107714_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0145-2126(93)90061-O","article-title":"Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia\/lymphoma","volume":"17","author":"Tsukasaki","year":"1993","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2025.107714_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF02983215","article-title":"Lymphoma study group of the japan clinical oncology group, deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan clinical oncology group study (JCOG9109)","volume":"77","author":"Tsukasaki","year":"2003","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2025.107714_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma: Japan clinical oncology group study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107714_bib10","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"Japan clinical oncology group study JCOG9801, VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107714_bib11","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12185-018-02588-5","article-title":"JSH practical guidelines for hematological Malignancies, 2018: II. Lymphoma-8. Adult T-cell leukemia-lymphoma","volume":"109","author":"Tsukasaki","year":"2019","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2025.107714_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107714_bib14","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/cas.13398","article-title":"Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010\u20132011: a nationwide survey","volume":"108","author":"Nosaka","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107714_bib15","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1111\/cas.14658","article-title":"Prognosis of patients with adult T-cell leukemia\/lymphoma in Japan: a nationwide hospital-based study","volume":"111","author":"Imaizumi","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107714_bib16","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"ATL-Prognostic Index Project, treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2141.1999.01323.x","article-title":"Diversity of leukemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype, and defective HTLV-1 genotype","volume":"105","author":"Tsukasaki","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107714_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12185-012-1020-2","article-title":"Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL","volume":"95","author":"Kamihira","year":"2012","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2025.107714_bib19","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V73.6.1664.1664","article-title":"Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia","volume":"73","author":"Shirono","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib20","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-13-3169","article-title":"CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I\u2013infected cells in adult T-cell leukemia\/lymphoma","volume":"20","author":"Kobayashi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2025.107714_bib21","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1111\/cas.14219","article-title":"CD4+\u2009CADM1+\u2009cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia\/lymphoma","volume":"110","author":"Makiyama","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107714_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053728","article-title":"The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I","volume":"8","author":"Kobayashi","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.leukres.2025.107714_bib23","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/1097-0142(19910515)67:10<2605::AID-CNCR2820671034>3.0.CO;2-L","article-title":"Prognostic significance of the proportion of Ki-67-positive cells in adult T-cell leukemia","volume":"67","author":"Yamada","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2025.107714_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1014471500757","article-title":"Genetic instability of adult T-cell leukemia\/lymphoma by comparative genomic hybridization analysis","volume":"22","author":"Tsukasaki","year":"2002","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.leukres.2025.107714_bib25","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1182\/blood.V97.11.3612","article-title":"Cytogenetic analysis and clinical significance in adult T-cell leukemia\/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki","volume":"97","author":"Itoyama","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib26","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1158\/0008-5472.CAN-14-0643","article-title":"Molecular characterization of chronic-type adult T-cell leukemia\/lymphoma","volume":"74","author":"Yoshida","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2025.107714_bib27","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1349-7006.2001.tb02151.x","article-title":"Possible involvement of interferon regulatory factor 4 (IRF4) in a clinical subtype of adult T-cell leukemia","volume":"92","author":"Imaizumi","year":"2001","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.leukres.2025.107714_bib28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2025.107714_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3960\/jslrt.20019","article-title":"Clinical application of genomic aberrations in adult T-cell leukemia\/lymphoma","volume":"60","author":"Kataoka","year":"2020","journal-title":"J. Clin. Exp. Hematop."},{"key":"10.1016\/j.leukres.2025.107714_bib31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.2021013568","article-title":"Whole-genome landscape of adult T-cell leukemia\/lymphoma","volume":"139","author":"Kogure","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib32","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood.2019002665","article-title":"Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia\/lymphoma diagnosis","volume":"135","author":"Rowan","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib33","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41467-021-25101-9","article-title":"Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma","volume":"12","author":"Yamagishi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2025.107714_bib34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jha2.776","article-title":"Progression of adult T-cell leukemia\/lymphoma from smoldering to acute type due to branched subclonal evolution","volume":"4","author":"Jimbo","year":"2023","journal-title":"EJHaem"},{"key":"10.1016\/j.leukres.2025.107714_bib35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107714_bib36","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107714_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.2019004045","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"137","author":"Cook","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib38","first-page":"293","article-title":"High-risk aggressive lymphoma (ATL)","volume":"42","author":"Yamada","year":"2001","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.leukres.2025.107714_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1346-8138.2012.01639.x","article-title":"Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese skin cancer society \u2013 lymphoma study group","volume":"40","author":"Sugaya","year":"2013","journal-title":"J. Dermatol."},{"key":"10.1016\/j.leukres.2025.107714_bib40","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10147-024-02579-z","volume":"29","author":"Matsumura","year":"2024","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107714_bib41","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1346-8138.12374","article-title":"Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma","volume":"41","author":"Tsukasaki","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.leukres.2025.107714_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/02841860802657235","article-title":"Adult T-cell leukemia\/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases","volume":"48","author":"Bittencourt","year":"2009","journal-title":"Acta Oncol."},{"key":"10.1016\/j.leukres.2025.107714_bib44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12185-017-2361-7","article-title":"Long-term clinical remission maintained after cessation of zidovudine and interferon-\u03b1 therapy in chronic adult T-cell leukemia\/lymphoma","volume":"107","author":"Cook","year":"2018","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2025.107714_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood-2017-01-757542","article-title":"Prognostic index for chronic- and smoldering type adult T cell leukemia-lymphoma","volume":"130","author":"Katsuya","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12185-022-03473-y","article-title":"Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study","volume":"117","author":"Imaizumi","year":"2023","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2025.107714_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12185-019-02602-4","article-title":"Clinical features at transformation in adult T-cell leukemia-lymphoma with smoldering and chronic types","volume":"109","author":"Taniguchi","year":"2019","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2025.107714_bib48","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2141.2008.07351.x","article-title":"Smouldering adult T-cell leukaemia\/lymphoma: a follow-up study in Kyushu","volume":"143","author":"Ishitsuka","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107714_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hon.2574","article-title":"Prognostic impact of soluble interleukin-2 receptor level profiling in smoldering type adult T-cell leukemia-lymphoma","volume":"37","author":"Kubota","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.leukres.2025.107714_bib50","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","article-title":"Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease","volume":"89","author":"Tsukasaki 1","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107714_bib51","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/cas.13641","article-title":"Evaluation of two prognostic indices for adult T-cell leukemia\/lymphoma in the subtropical endemic area, Okinawa, Japan","volume":"109","author":"Tamaki","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107714_bib52","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:31:06Z","timestamp":1762245066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":52,"alternative-id":["S0145212625000748"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107714","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment strategy for indolent adult T-cell leukemia-lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107714"}}